ASN: Caffeine Associated With Reduced Mortality in CKD
Chronic kidney disease patients in highest quartile of caffeine consumption have lowest risk for mortality
GLP-1 May Mediate Effects of Gastric Bypass on CNS Activation
After Roux-en-Y, CNS activation reduced in response to food cues, GLP-1 levels significantly elevated
Driving Impairment Warnings Often Not Given With Rx Meds
For most drug categories, those who do receive warnings perceive higher risk of impaired driving
Midlife Systemic Inflammation Tied to Late-Life Brain Volume
Smaller hippocampal, Alzheimer's signature region volumes seen 24 years after inflammation noted
PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations
Race a Factor in Intracranial Atherosclerotic Disease
Prevalence and frequency of multiple plaques were higher for black men
Inflammatory Biomarkers May Impact Risk of Schizophrenia
Protective effect noted for C-reactive protein; risk-increasing effect for soluble interleukin-6 receptor
October 2017 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for October 2017. This roundup includes the latest...
Hepatitis B Viral Load, Surface Antigen May ID Liver Cancer Risk
Increased risk of liver cancer linked to hepatitis B DNA, surface antigen in a dose-response manner
CMS Launches Initiative to Examine Impact of Regulations
Officials set to travel country gathering information on impact of their regulations on physicians
